SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.
종목 코드 SGP
회사 이름SpyGlass Pharma Inc
상장일- -
CEO- -
직원 수- -
유형Ordinary Share
회계 연도 종료- -
주소27081 Aliso Creek Road
도시
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호92656
전화
웹사이트
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음